(A and B) Growth curve (A) and total body weight gain over 6 weeks (B) in 4-week-old WT and Prmt5MKO mice (n = 7/group).
(C) Survival of adult WT and Prmt5MKO mice; all KO mice died before reaching 18 weeks old (n = 15).
(D) Lean and fat mass of 8-week-old WT and Prmt5MKO mice (n = 6) measured by EchoMRI body composition analyzer.
(E) Weight of soleus (SOL), extensor digitorum longus (EDL), tibialis anterior (TA), gastrocnemius (GAS), and quadriceps (QU) muscles in adult WT and Prmt5MKO mice (n = 3).
(F) Myofiber morphology outlined by sarcolemma dystrophin immunofluorescence of TA muscle sections from WT and Prmt5MKO mice (n = 4). Scale bar, 100 μm.
(G) Frequency distribution of TA muscle myofiber cross-sectional area (CSA) in adult WT and Prmt5MKO mice (n = 4).
(H and I) Average myofiber CSA (H) and total myofiber number (I) per TA muscle of WT and Prmt5MKO mice (n = 4).
(J–L) Running time (J), maximum speed (K), and running distance (L) of adult WT and Prmt5MKO mice measured by treadmill exhaustion test (n = 5–7).
(M) Grip strength test normalized to body weight in adult WT and Prmt5MKO mice (n = 5–8).
(N and O) Absolute contractile force as a function of frequency of electric stimulation (left) and maximal absolute force (right) measured in the EDL (N) and SOL (O) muscles isolated from adult WT and Prmt5MKO mice (n = 4).
(P and Q) Specific force as a function of frequency (left) and maximal specific force (right) of EDL (P) and SOL (Q) muscles isolated from adult WT and Prmt5MKO mice (n = 4).
Values are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by t tests. See also Figure S1.